PATENT CLAIM ANALYSIS

Application Number: 15960087
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "180000"]

Abstract:
The present invention describes novel and improved dosage forms containing fluticasone propionate for the treatment of conditions associated with inflammation of the esophagus.

Claim (Index 27):
A viscous liquid dosage form comprising fluticasone propionate in combination with 0.5 wt % to 10 wt % of sodium alginate as viscosity enhancer and other non-active ingredients, said non-active ingredients comprising:\n (i) a sweetener agent; (ii) 0.1 wt % to 0.5 wt % of carbomer as suspending agent; (iii) 0.001 wt % to 0.01 wt % of polysorbate 80 as wetting agent; (iv) 0.06 wt % to 0.6 wt % of a mixture of methylparaben and propylparaben as preservative; and (v) sodium hydroxide, wherein the viscous liquid dosage form is formulated for oral administration, and wherein the viscous liquid dosage form has a pH of about 6 to about 8.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15612923', '14603224', '15795846', '15293535', '15181462']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608344102288646
- 35 USC 102 Novelty (BERT): 0.5352441367938212
- Combined Prediction Score: 0.7382753828853602
- Mean Citation Score: 259.03165
- Max Citation Score: 367.7427
- Similarity Product: 250.1467533072532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test